Par Pharmaceutical Reports EPS Of $0.76 For Third Quarter 2009 - Congoo

|

|

News

Media & Advertising

VENTURE CAPITAL

Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009

Have an interest in this Story?
Sign Up for Real-Time email updates

Forbes.com | November 06, 2009

WOODCLIFF LAKE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the third quarter ended October 3, 2009. For the third quarter ended October 3, 2009, Par reported total revenues of $294.8 million and net income of $26.3 million, or $0....

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

As deployment nears, will wavers - Washington Post

Obama job approval rating drops under 50 percent (Reuters) - Yahoo! News

Take a deep breath: Needles are on the way out - Asahi.com

Pakistani duo held in Italy for links to 26/11 - The Hindu

Police Sergeant Accused of Misconduct - ABC 7

Featured Members

Leo Petrik
Founder & CEO
Entrepreneur

THENNY MEJIA
Sr. Vice President
Healthcare Industry

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map

Copyright ©2009 Congoo.com. All Rights Reserved.